Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

The future of the weight loss market might not revolve around GLP-1 drugs.

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Ozempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...